Characterization of sleep apnea and hospitalization for severe illness due to COVID-19
Boletin de Malariologia y Salud Ambiental
; 62(2):306-312, 2022.
Artigo
em Espanhol
| CAB Abstracts | ID: covidwho-2033962
ABSTRACT
COVID-19 has generated considerable morbidity and mortality worldwide, particularly among those with chronic comorbidities hypertension, diabetes, and cardiovascular disease. Research has shown that sleep apnea can worsen the vital prognosis, by causing or exacerbating endothelial dysfunction, inflammation, oxidative stress, microaspiration and lung damage, which amplifies the risk of hospitalization and even respiratory failure. A retrospective and cross-sectional descriptive study was carried out, 187 heart patients with clinical signs suggestive of obstructive sleep apnea were evaluated and were positive for SARS-CoV-2, between 2020-2021. The methodology of Castro et al., 2021 and questionnaire were applied. STOP-BANG to assess dyspnea and characterize OSA, respectively. The strong association between heart disease and the presence of OSA was confirmed;More than half of the patients studied presented severe disease due to COVID-19, with moderate-severe dyspnea, which required hospitalization with intensive care, with a higher frequency observed in males, over 50 years of age and with BMI >30. However, females presented significant STOP-BANG values, which suggests hypertension and obesity as risk factors for OSA, regardless of gender. It is recommended to rule out OSA as a medical routine, which allows establishing the epidemiology and strategies for an adequate approach to these patients.
Non-communicable Human Diseases and Injuries [VV600]; Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Nutrition related Disorders and Therapeutic Nutrition [VV130]; blood pressure; body mass index; comorbidity; coronavirus disease 2019; cross-sectional studies; disease course; epidemiology; heart; heart diseases; human diseases; hypertension; obesity; overweight; respiration; respiratory diseases; retrospective studies; risk; risk assessment; risk factors; severe course; severe infections; viral diseases; women; acute course; acute infections; man; Severe acute respiratory syndrome coronavirus 2; Ecuador; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Andean Group; high Human Development Index countries; Latin America; America; South America; upper-middle income countries; obstructive sleep apnoea; disease progression; coronary diseases; high blood pressure; fatness; lung diseases; SARS-CoV-2; viral infections
Buscar no Google
Coleções:
Bases de dados de organismos internacionais
Base de dados:
CAB Abstracts
Idioma:
Espanhol
Revista:
Boletin de Malariologia y Salud Ambiental
Ano de publicação:
2022
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS